Firms form alliance to work on COVID-19 therapy
The alliance will immediately start work on the development of an unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobulin medicine
Read More
Tag: plasma
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
